Clinical Trials Directory

Trials / Unknown

UnknownNCT01758107

Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Chulalongkorn University · Academic / Other
Sex
All
Age
15 Years – 85 Years
Healthy volunteers
Not accepted

Summary

Study safety of longterm immunosuppressive protocol with Sirolimus plus Prednisolone, and Calcineurin inhibitor withdrawal.

Detailed description

Sirolimus with Cyclosporine minimization is the standard protocol for kidney transplantation in Chulalongkorn University. The investigators published the safety of this regimen in Transplantation Proceeding 2008; 40: 2206-8. The investigators now further study in those patients who doing well with this regimen more than 1 year. The patients will be asked for kidney biopsy to evaluate and make sure they don't have subclinical rejection. The patients who don't have subclinical rejection will discontinue cyclosporine and continue with only sirolimus and prednisolone.

Conditions

Interventions

TypeNameDescription
OTHERWithdraw cyclosporine

Timeline

Start date
2010-08-01
Primary completion
2013-08-01
Completion
2015-10-01
First posted
2013-01-01
Last updated
2015-02-03

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT01758107. Inclusion in this directory is not an endorsement.